D. Strable Soethout - 13 May 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: Director
Issuer ticker: ELV
Reported as of: 13 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2026, 16:33:51 UTC
Prior SEC filing: 31 Mar 2026
Next SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

D. Strable Soethout filed Form 4 for Elevance Health, Inc. (ELV) on 15 May 2026.

Key facts

This page summarizes D. Strable Soethout's Form 4 filing for Elevance Health, Inc. (ELV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2026, 16:33.

Change

Previous filing in this sequence was filed on 31 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001278726 Primary reporting owner

STRABLE-SOETHOUT DEANNA D

Relationship: Director
Address: 220 VIRGINIA AVENUE, INDIANAPOLIS
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Signature date: 15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Award

Transaction value
Shares: +563
Change %: +34%
Price: $0.000000^*
Shares after: 2,209
Date: 13 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

Footnote F2

The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.